Detection of Borrelia burgdorferi DNA in museum specimens of Peromyscus leucopus.
Author information
- 1Department of Tropical Public Health, Harvard School of Public Health, Boston, Massachusetts.
The Los Angeles Times (5/30, Morin) reports recent research published in Historical Biology found a tick trapped 15 million years ago in an amber droplet may have been infected with a bacteria resembling Lyme disease. The tick was found in the present-day Dominican Republic. Of four ticks found, only one appeared to carry the disease, "suggesting that it either inherited the bacteria from its mother or obtained it from an animal it had seized on for a blood meal
from: http://mentalillnesspolicy.org/national-studies/commitmenthomiciderates.html
By Michele McDonald
Worried that tick bite means Lyme disease? Mason researchers can find the answer well before the bite victim begins to show symptoms.
"If you are bit by a tick, you can't be sure if you will get Lyme disease―that is the biggest problem right now," says Mason researcher Alessandra Luchini of the Center for Applied Proteomics and Molecular Medicine.
Luchini and other Mason researchers are evaluating a new type of diagnostic test they developed for humans and their canine pals to pinpoint tiny signs of the bacteria that lead to Lyme disease. A study of the new type of test is underway. The test soon could be available commercially through privately held Ceres Nanosciences Inc., which partnered with Mason to develop the test and plans to market it to doctor's offices and veterinary clinics.
The culprit is the blacklegged tick. It can carry the bacterium Borrelia burgdorferi, which leads to Lyme disease. To make matters worse, nymphs―about the size of the period at the end of this sentence―can bite unnoticed until the standard first sign of Lyme disease, a bull's-eye rash, appears.
Joint and muscle aches, fatigue, fever, chills, headaches, and swollen lymph nodes typically come next, according to the Centers for Disease Control and Prevention.
A dose of antibiotics usually kills the bacteria, but sometimes symptoms persist. Patients return to their doctor months and even years later, convinced they still have Lyme disease, says Lance Liotta, the co-director of the center. Until now, there was no way of knowing definitively if the disease was still active or not.
Current blood tests only show if the body has created antibodies to fight the infection. Antibodies remain even after the infection is beaten.
But the active Lyme disease bacterium sheds a very small piece of itself called an antigen while it's doing damage. In the past, these nanoparticles were too small to test. But thanks to technology developed at center, researchers can now use a "nanotrap" to capture the antigen in urine.
The patented nanotrap works much like a lobster trap, Liotta says. It's an open meshwork with bait inside. The traps look like tiny white balls under the microscope. "The protein that we want goes in and gets stuck inside," Liotta says. "It binds to that bait in the trap."
The researcher plucks out the antigen, which is protected while in the trap. If the antigen shed byBorrelia burgdorferi is found, then the patient has an active case of Lyme disease, Luchini says.
"The antigen is a component of the toxic-causing agent itself," Luchini says. "Instead of looking at the host response or whatever the human body does to fight the infection, we look at a piece of the infection-causing agent. Everyone measures the antibodies because it's much easier."
And it's those antibodies that can cause problems, Liotta says. Antibodies fight infection and react to the proteins in the bacteria. But antibodies don't stop with the infection—they move to attack proteins in the nerves, joints, and brain, Liotta says.
"The bacterium doesn't directly cause the damage," Liotta says. "It's the immune response that's doing the damage. The goal is to have a way to detect Lyme disease even before you make antibodies against it. Then you could treat the patient with antibiotics, and they wouldn't get all those terrible symptoms. Or, if someone has joint problems and they're convinced they have Lyme disease—and there are thousands of people who feel that way—it gives us a way to definitively say they do or don't have Lyme disease."
The inspiration for the test started about two and a half years ago when a high school student from Lucketts, Virginia, joined Mason's Aspiring Scientists Summer Internship Program and worked with Luchini and Liotta. Temple Douglas, now a junior at Princeton University, had family members who suffered from Lyme disease.
She even collected the first round of ticks for the initial work on the test. "I lived in the countryside, so whenever people found ticks on their animals or crawling on their pants after they went hiking, I would take them with me to the lab," Douglas says.
Ceres Nanosciences raised $1 million late last year, due in large part to the commercial potential of the Lyme disease diagnostic test, says Ross Dunlap, its chief executive officer. The results could do more than boost the company's bottom line, he says.
"It would be good not to be flooding every tick bite with antibiotics," Dunlap says.
By PR Newswire: Biotechnology
Friday, 23 May 2014 05:00
ARLINGTON, Va., May 23, 2014 /PRNewswire/ -- Lyme activists, who have the Infectious Diseases Society of America headquarters surrounded and under siege, issued a call for a Congressional Investigation of corruption within the CDC, IDSA, and the vaccine industry.
According to Lyme researcher and activist, Carl Tuttle, "An investigation is long overdue. The conflicts of interest and improper influence among these originations has contributed to terrible suffering and financial losses for thousands of people."
Tuttle suffered from Lyme disease for twelve years and was misdiagnosed and denied treatment by multiple doctors before he was finally diagnosed with late stage Lyme disease. Despite receiving the IDSA recommended treatment, Tuttle remained ill and was bedridden on oxygen for several months.
New York Times bestselling author Dr. Joseph Mercola says, "Conflicts of interest are rampant in the vaccination infrastructure. The same people who are regulating and promoting vaccines are also evaluating vaccine safety."
In November 2006, Connecticut Attorney General Richard Blumenthal, now a U.S. Senator, launched an investigation of IDSA based on allegations of abuses of monopoly power and exclusionary conduct in the development of their guidelines, in violation of antitrust law.
In a May 2008 press release Blumenthal said, "My office uncovered undisclosed financial interests held by several of the most powerful IDSA panelists. The IDSA's guideline panel improperly ignored or minimized consideration of alternative medical opinion and evidence regarding chronic Lyme disease, potentially raising serious questions about whether the recommendations reflected all relevant science."
IDSA has consistently opposed patient-centered legislation. At IDSA's 2006 annual meeting "Defeat Patient Sponsored Legislation" was a top agenda item.
Mayday Project coordinator Josh Cutler is concerned about the adversarial relationship between the IDSA and patients. He says, "IDSA's response to the epidemic of chronic Lyme disease is to pretend it doesn't exist. Thousands of people suffer as a result. Instead of working for the benefit of patients, IDSA works to block legislation that would help patients."
In April 2014 Senator Bill Posey (R-FL) called for a Congressional investigation into conflicts of interests and corruption within the CDC and vaccine industry. Posey described "Huge conflicts of interest and a misinformation campaign conducted on behalf of the CDC. Their little media network twist[s] the truth to disparage, to malign, to vilify, to denigrate anybody who wants any kind of accountability."
Sources:
http://www.biomedreports.com/20140523182513/lyme-warriors-call-for-congressional-investigation-of-cdc-idsa-vaccine-makers.html
For more information visit www.themaydayproject.org
Press Release Contact Information:
Susan Harris
Media Relations
TeamCom
seharris4@verizon.net
This release was issued through WebWire®. For more information visit http://www.webwire.com.
Press Release URL:
http://www.webwire.com/ViewPressRel.asp?aId=188062
SOURCE Mayday Project
RELATED LINKS
http://www.themaydayproject.org
Read more http://www.prnewswire.com/news-releases/lyme-warriors-call-for-congressional-investigation-of-cdc-idsa-vaccine-makers-260391261.html
Inanna House: A New and Greatly Anticipated Hope For All Lyme Patients
From Public Health Alert, Nov 2012 by Sarah Lamando You may or may not have heard about it, but there has recently been quite a stir within the Lyme Community regarding an organization called "Inanna House," one that is giving them something they haven't seen in years...hope. Inanna House is an organization that intends on building the very first inpatient, residen- tial, holistic recovery center for Chronic Lyme Disease patients. The program would include all worlds of medicine, and is designed to address every aspect of healing; mind, body and spirit. Some of the Highlights of this visionary center include: designed to help care-takers understand exactly what their loved ones are going through, and how Lyme dis- ease and its co-infections are affecting them. This program will also give specific instructions so that care-takers will know how they can help their loved ones recover. The Center intends to incorporate Green Energy to help run the facility and make it as self-sustainable as possible. This will not only be good for the environment, but will also lower overhead cost, and thus, patient fees. 24 Hour Care and moni- toring by Lyme Literate Healthcare Professionals as patients undergo individual- ized treatment plans to achieve optimal re-integra- tion and healing. and specific therapies the center intends on offering, please visit their website at: http://www.inannahouse.org /our-vision.html The conception of such a place could only have come from someone who has wit- nessed the devastation, financial ruin, and complete abandonment by the current healthcare system regarding the treatment of anyone who has been caught in the mid- dle of this current medical nightmare, especially since it happened to her own daugh- ter. Her name is Mara Williams, author of the book, "Nature's Dirty Needle" and Certified Nurse Practitioner with over 30 years of experi- ence as a health-care provider. So shocked at what she and her daughter had to go through in order to receive proper treatment, that she courageously decid- ed it was simply unaccept- able, and has ever since been fighting to see her vision for this unparalleled center be built. She is adamant in her belief that the current healthcare system is "bro- ken," possibly beyond repair, and that a "New Paradigm" is desperately needed. Her center will be the first of many to model this new par- adigm as she intends to have numerous centers all over the country, the first to be built in Sonoma, California. Currently, a campaign is being held on indiegogo.com, created by a single Chronic Lyme Disease Patient, Sarah Lamando, who after helplessly watch- ing her family be torn apart over her illness, chose this organization because she knows that although she could not prevent it from happening to her, Inanna House might be able to pre- vent it from happening to others. She believes in Mara's vision SO strongly that she has tirelessly attempted to raise funds that would literally expedite the creation of this center, and bring it one step closer to a sorely needed reality. To view the campaign, please visit http://indiegogo.com /InannaHouse ANY contributions towards this cause would be much appreciated. Even those who cannot contribute, can still help make the cam- paign a success by sharing it with others through social medias or by direct e-mails. If successful, Inanna House would gain global exposure and media attention which could only further accelerate the building process of this amazing center. |
Governor Peter Shumlin signed a bill Thursday aimed at giving doctors more latitude to treat long-term symptoms of tick-borne illnesses, which advocates lauded as a good first step.
"We have one of the highest rates of Lyme disease in America, per capita, and what we know about Lyme disease is that if not detected early it is an extraordinarily debilitating disease that can uproot the life of an otherwise very healthy Vermonter," Shumlin said.
The number of confirmed cases of Lyme disease in Vermont grew from 11 in 2002 to 674 in 2013. Shumlin encouraged Vermonters to become educated about the symptoms of Lyme and check themselves regularly for ticks.
The law requires the state Board of Medical Practice to issue a memo saying that it won't censure clinicians for using alternative methods to treat patients with ongoing symptoms of Lyme and other related diseases.
Lyme disease and other tick-borne illnesses are typically treated upon diagnosis with a two- to four-week course of antibiotics, and if caught early, the disease is unlikely to have lasting health effects. However, if it's not detected early, it can be difficult to diagnose and treat.
There is medical controversy over the benefit of using long-term antibiotics to treat persistent symptoms of those illnesses.
Centers for Disease Control and Prevention guidelines advise against long-term antibiotic treatment. The agency points to studies that show prolonged antibiotic treatments don't lead to better outcomes than placebos and can lead to serious complications.
But the International Lyme and Associated Diseases Society provides guidelines for the treatment of persistent Lyme that include prolonged antibiotics as an effective treatment. The society is a nonprofit medical group focused on the diagnosis and treatment of Lyme and associated diseases.
Advocates said it's difficult to find doctors who will treat their symptoms using longer courses of antibiotics, forcing patients to go out of state for treatment in some cases.
Carol Gardner, a family medicine doctor in Colchester, who frequently treats patients for lingering symptoms of Lyme disease, said the bill gives her peace of mind.
Gardner said she's never experienced any direct pressure from the Board of Medical Practice or the Vermont Medical Society, but she said, "We know they have a more conservative view."
The board's job is to enforce medical standards and because Lyme is an emergent problem, those standards don't endorse alternative treatments, Gardner said.
David Herlihy, executive director the Board of Medical Practice, has said there are no public cases of physicians being sanctioned for prescribing antibiotics to treat Lyme in a way that didn't mesh with the board's guidelines.
Investigations of complaints against physicians only become public when they result in charges or a stipulation against physicians.
Dr. Harry Chen, commissioner of the Department of Health and a past member of the board, has said there are other ways, short of a stipulation, that the board can exert influence on a provider, but he has not seen it used to discourage a specific treatment.
"(The law) removes restrictions, or perceived restrictions, on doctors from being able to practice a range of medical care for people with Lyme," said Sen. David Zuckerman, P/D-Chittenden, who joined the governor, several other lawmakers and activists who pushed for the new law – many of whom suffer from the ongoing symptoms of Lyme or have loved ones who do.
Zuckerman's wife, Rachel Nevitt, attended the bill signing as well. Nevitt has Lyme disease and her symptoms have taken an emotional toll on their marriage and impacted their family business, he said.
Patients like Nevitt suffering with prolonged symptoms can experience severe fatigue, headaches, joint pain and anxiety.
"Prevention is the most important thing, second is early detection," Zuckerman said, adding that he hopes the new law will bring greater awareness of the signs of Lyme among health care providers and the public.
Bernadette Rose has struggled with persistent symptoms of Lyme and spent nearly a decade advocating for legislation to protect physicians and increase education around alternative treatments.
She said the bill is a step in the right direction, but she hopes the medical community will include the guidelines for treatment endorsed by the International Lyme and Associated Disease Society as part of continued education for physicians.
"Bartonella bacteria are highly evolved, survive in multiple insect vectors and in dessicated flea feces, and enter our bodies in a stealth-like manner, switching off our immune response as it takes residence in our tissues.
"It persists despite aggressive treatment and is clearly a contender for diseases transmitted by blood transfusions. Physicians must be cognizant of the stealth nature of this pathogen and the alarmingly high frequency of seronegativity."
Scroll down and you will see "7 responses to the article. One said, "Dr Jemsek of "under our skin" movie fame put me on 600mg Omnicef, 1000 mg Azithromyacin and 200mg Minocyn every other day (cyclical). HUGE improvement. I also am taking 100 BILLION probiotics and numerous nutracells a day for immune suppression problems. People with severe issues need to look into Infectious Mycoplasma infection as a coinfection. Google IMMED or Prof Garth Nicolson."
It would be important to use antibiotics that have good intracellular penetration, and that will provide effective treatment against the Bartonella while inside the infected cells, but what are they? We need research to find that out…...As far as the diagnosis, realize that there is no such thing as a negative Bartonella test. Testing can only confirm a clinical diagnosis. Studies indicate that the standard Bartonella testing accuracy may be as low as 18%. Tragic if your doctor does not know that. While costly, for both you and them, Galaxy Diagnostic's highest priority is to provide the most accurate Bartonella testing. They do, but be aware that even they get false negatives, and even their testing can only confirm a clinical diagnosis.
|